» Authors » Silverio Perrotta

Silverio Perrotta

Explore the profile of Silverio Perrotta including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 179
Citations 2896
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Zanfardino A, Ozen G, Ippolito G, Roberti D, Perrotta S, Iafusco D, et al.
Diabetes Res Clin Pract . 2025 Mar; 222:112076. PMID: 40032039
Aims: Continuous Glucose Monitoring (CGM) may help detect early dysglycemia in Transfusion-Dependent Thalassemia (TDT) patients, though previous reports suggest it may overestimate prediabetes prevalence. This study analyzed glucose-related metrics in...
2.
Bordoni V, Cinicola B, Piano Mortari E, Castilletti C, Guarracino F, Albano C, et al.
Am J Hematol . 2025 Feb; PMID: 39953916
Splenectomy or congenital asplenia is associated with severe reduction of memory B cells and increased risk of fulminant sepsis by encapsulated bacteria. Current guidelines recommend vaccinations against these pathogens before...
3.
Casale M, Scianguetta S, Palma T, Pinfildi L, Vallefuoco G, Capellupo M, et al.
Eur J Pediatr . 2025 Jan; 184(2):157. PMID: 39875760
Conclusions: A screening program for SCD performed by the primary care paediatricians is feasible and relatively easy to organize. SCD affects mainly children with African family background and the scarce...
4.
Gianesin B, Piel F, Musallam K, Barella S, Casale M, Cassinerio E, et al.
Haematologica . 2025 Jan; PMID: 39844751
Not available.
5.
Casale M, Toro G, Porcelli F, Quota A, Rosso R, Spadola V, et al.
Br J Haematol . 2024 Sep; 206(1):310-319. PMID: 39344565
Avascular necrosis (AVN) is a prevalent and progressive complication in young patients with sickle cell disease (SCD), but no study evaluated the long-term subjective and objective outcome measures. Oxford hip...
6.
Cavallo N, Maietta P, Perrotta S, Moretta P, Carotenuto M, Esposito M, et al.
Children (Basel) . 2024 Aug; 11(8). PMID: 39201967
Background: Neurofibromatosis type 1 (NF1) is a genetic disorder that affects multiple systems in the body, often leading to physical disfigurements and a wide range of clinical symptoms. This study...
7.
Mastromoro G, Santoro C, Motta M, Sorrentino U, Daniele P, Peduto C, et al.
Genet Med . 2024 Aug; 26(11):101241. PMID: 39140257
Purpose: Pathogenic LZTR1 variants cause schwannomatosis and dominant/recessive Noonan syndrome (NS). We aim to establish an association between heterozygous loss-of-function LZTR1 alleles and isolated multiple café-au-lait macules (CaLMs). Methods: A...
8.
Rivetti G, Abbate F, Longobardi M, Marrapodi M, Lanzaro F, Di Martino M, et al.
Ital J Pediatr . 2024 Jul; 50(1):131. PMID: 39075575
Background: Transient erythroblastopenia of childhood (TEC) is an acquired, self-limited pure red cell aplasia that usually occurs in children 4 years old and younger. This clinical condition has been priorly...
9.
Manara R, Ponticorvo S, Contieri M, Canna A, Russo A, Fedele M, et al.
Orphanet J Rare Dis . 2024 May; 19(1):212. PMID: 38773534
Background: Brain injury in hereditary hemoglobinopathies is commonly attributed to anemia-related relative hypoperfusion in terms of impaired oxygen blood supply. Supratentorial and infratentorial vascular watershed regions seem to be especially...
10.
Manara R, Brotto D, Barillari M, Costa G, Villani A, Perna C, et al.
Br J Haematol . 2024 Mar; 204(5):2016-2024. PMID: 38500389
Background: Despite numerous studies, the true scenario of hearing loss in beta-thalassaemia remains rather nebulous. Materials And Methods: Pure tone audiometry, chelation therapy, demographics and laboratory data of 376 patients...